During the past decade, Auckland District Health Board conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auckland District Health Board" #1 sponsor was "Asahi Kasei Pharma America Corporation" with 1 trials, followed by "CTI BioPharma" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auckland District Health Board" #1 collaborator was "American College of Rheumatology" with 1 trials as a collaborator, "Auckland District Health Board" with 1 trials as a collaborator, "Cairns Hospital" with 1 trials as a collaborator, "Centre Hospitalier Regional de la Citadelle" with 1 trials as a collaborator and "Cornell University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Auckland District Health Board" are "Anesthesia Awareness" (1 trials), "Churg Strauss Syndrome" (1 trials), "Coagulopathy" (1 trials), "Cystic Fibrosis" (1 trials) and "Giant Cell Arteritis" (1 trials). Many other conditions were trialed in "Auckland District Health Board" in a lesser frequency.

Most popular intervention types in "Auckland District Health Board" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ART-123" (1 trials), "AZLI 75 mg three times a day (TID)" (1 trials), "Best Available Therapy" (1 trials) and "IFT Testing 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Auckland District Health Board" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Auckland District Health Board". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Auckland District Health Board, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Auckland District Health Board, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Auckland District Health Board has several departments that took part in Clinical trials: "Auckland City Hospital, Cancer and Blood Research" - 19 trials, "Auckland City Hospital (DCCM)" - 9 trials, "Starship Children's Hospital" - 71 trials, "Auckland City Hospital; Clinical Oncology" - 5 trials, "Auckland Hospital; New Zealand Liver Transplant Unit" - 3 trials